Body mass index at diagnosis, postdiagnosis change, and role of metabolic comorbidities in relation to survival in nonmetastatic renal cell carcinoma patients.
Sarker M, Deng Z, Kauffman EC, Tang L, Kwan ML, Langston ME, Gupta S, Grass GD, Singer EA, Zakharia Y, Viscuse PV, Graham L, Ghodoussipour S, Salhia B, Kern SQ, Ayanambakkam A, Myint Z, King J, Oderinde S, Churchman ML, Rounbehler RJ, Batai K